Steris (STE) Return on Capital Employed (2019 - 2026)
Steris' (STE) quarterly Return on Capital Employed came in at 11.57% in Q1 2026, up 200.0% year-on-year from 3.86% in Q1 2025, and up 10.75% quarter-over-quarter from 10.45% in Q4 2025.
Steris (STE) Return on Capital Employed (2019 - 2026) Analysis & Trends
Steris' Return on Capital Employed history runs 8 years deep, the most recent figure standing at 11.57% for Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 200.0% year-over-year to 11.57% in Q1 2026; TTM through Mar 2026 was 11.57%, a 200.0% increase from a year earlier, with the FY2026 full-year figure at 11.85%, up 281.0% from the prior year.
- Return on Capital Employed advanced to 11.57% in Q1 2026 per STE's latest filing, from 10.45% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 13.08% in Q3 2023 and bottomed at 1.9% in Q4 2022.
- The 5-year median for Return on Capital Employed is 9.09% (2024), against an average of 8.45%.
- Across the five-year window, Return on Capital Employed jumped 1116 bps in 2023 and sank 398 bps in 2024, its largest moves.
- Year by year, Return on Capital Employed stood at 1.9% in 2022, then jumped by 588 bps to 13.06% in 2023, then decreased by 28 bps to 9.43% in 2024, then climbed by 11 bps to 10.45% in 2025, then climbed by 11 bps to 11.57% in 2026.
- Per Business Quant, the three latest STE Return on Capital Employed figures stand at 11.57% (Q1 2026), 10.45% (Q4 2025), and 10.22% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 11.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.57% |
| Dec 31, 2025 | 10.45% |
| Sep 30, 2025 | 10.22% |
| Jun 30, 2025 | 9.92% |
| Mar 31, 2025 | 9.57% |
| Dec 31, 2024 | 9.43% |
| Sep 30, 2024 | 9.09% |
| Jun 30, 2024 | 8.45% |
| Mar 31, 2024 | 8.10% |
| Dec 31, 2023 | 13.06% |
| Sep 30, 2023 | 13.08% |
| Jun 30, 2023 | 8.37% |
| Mar 31, 2023 | 7.95% |
| Dec 31, 2022 | 1.90% |
| Sep 30, 2022 | 2.00% |
| Jun 30, 2022 | 5.98% |
| Mar 31, 2022 | 4.49% |
| Dec 31, 2021 | 3.08% |
| Sep 30, 2021 | 2.49% |
| Jun 30, 2021 | 3.69% |